Cover Image
市場調查報告書

冠狀動脈支架:全球趨勢及預測

Coronary Stents - Global Trends, Estimates and Forecasts, 2012-2018

出版商 Axis Research Mind 商品編碼 307201
出版日期 內容資訊 英文 615 Pages; 222 Tables/Charts
商品交期: 最快1-2個工作天內
價格
Back to Top
冠狀動脈支架:全球趨勢及預測 Coronary Stents - Global Trends, Estimates and Forecasts, 2012-2018
出版日期: 2014年11月11日 內容資訊: 英文 615 Pages; 222 Tables/Charts
簡介

全球冠狀動脈支架市場預測到2016年前將達到95億美元。北美是全球最大市場,約佔全球市場的41%,歐洲次之,約佔29%。亞太地區是成長最快速的市場,預測到2015年將成長到15億美元的規模。就產品別來看,藥劑溶出性血管支架市場到2015年前將佔40%以上的佔有率。

本報告提供冠狀動脈支架市場現狀與今後的預測,彙整加入此市場的主要企業簡介,市場佔有率,銷售額預測,以及合併,收購等策略性活動等。

第1章 報告的焦點

  • 簡介
  • 心血管設備
  • 冠狀動脈支架
    • 支架技術的進步
  • 冠狀動脈支架塗料的種類
  • 美國心臟支架的使用
  • 藥劑溶出性血管支架
  • 傳統金屬支架
  • 可吸收支架/生物分解性金屬支架
  • 防止血管再阻塞設備
  • 冠狀動脈支架:種類與支架塗料:市場概要
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 其他

第2章 市場分析

  • 冠狀動脈支架:產業概要
  • 冠狀動脈支架:市場區隔
  • 冠狀動脈支架:全球
  • 冠狀動脈支架:各類型
    • 傳統金屬支架
    • 可吸收支架
    • 防止血管再阻塞設備
  • 冠狀動脈支架:支架塗料別
  • 成長率分析
  • 投資的焦點

第3章 產業概要

  • 心臟各醫療設備檢討
    • 心律管理設備
    • 心臟整流去顫器
    • 心律調節器
    • 心臟再同步化治療
    • 心臟監測·診斷設備
    • 介入性心臟設備
    • 心導管
    • 電生理學導管
    • EP MAPPING
    • 心房纖維顫動
    • 血管內超音波
    • 末梢血管設備
    • 末梢血管導管導引線
    • 人工心臟瓣膜
  • 心臟設備:死亡率風險與年齡
  • 心臟疾病:經濟預測
  • 非洲等方面的感染和心血管疾病
  • 心血管設備近幾年的FDA措施與認證
  • 市場趨勢
  • 主要企業簡介

第4章 產業參與企業資料庫

第5章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: ARMMR129N.1

Global Coronary Stents sector is projected to reach US$9.5 billion by 2016. The North America accounts for nearly 41% (2015) of the global value while Europe claims approximately 29% (2018). Asia-Pacific is the fastest growing region with a CAGR of 8.8% driving a market value of US$1.5 billion by 2015. On a global scale, projections for drug eluting stents market share indicate more than 55% by 2015 leaving the rest of the market to the bare metal stents and other devices. By Coating, Polymer stent coating segment is the fastest growing market with a CAGR of 8.7% for analysis period 2012-2018.

Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.

Report Focus:

The report 'Coronary Stents - Global Trends, Estimates and Forecasts, 2012-2018 ' reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for market start-ups, pharmaceutical/biotechnology companies, laboratories, Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyers and many more in preferred locations. The report primarily focuses on:

  • Emerging Market Trends
  • Advancements in the Technological Space
  • Market Demand of The Segments (By-Region)
  • Key Growth Areas and Market Size
  • Region-Wise Demand Factor
  • Key Competitors Edge
  • Investment Strategies

The analysis primarily deals with by type & stent coating. Further, the subdivided categories include:

Coronary Stents - By Type & Stent Coating

  • By Type
    • a. Drug-Eluting Stents (DES)
    • b. Bare Metal Stents (BMS)
    • c. Absorbable Stents/Biodegradable Metallic Stent
    • d. Anti-Restenosis Devices
      • i. Bioactive Stent
      • ii. Radioactive Stent
      • iii. Drug-Eluting Balloon
  • By Stent Coating
    • a. Inorganic (PERSE, Gold, Silicon Carbide, Iridium Oxide, Carbon, Titanium-Nitride-Oxide)
    • b. Polymer (Biodegradable & Non-Biodegradable)
    • c. Non-Polymer (Microporous, Microstructured, Slotted Tubular, Nanoporous, Nanopatterned)
    • d. Other Coatings (Heparin, Hyaluronic Acid, Fibrin), Technologies & R&D

The period considered for the coronary stents market analysis is 2012-2018. The region wise distribution of the market consists of North America (USA and Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Belgium and Rest of Europe), Asia-Pacific (Japan, China, India, New Zealand, South Korea, Australia and Rest of Asia-Pacific)), Latin America (Brazil, Argentina and Rest of Latin America) and Rest of World (South Africa, Middle East and Rest of Rest of World). The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually.

More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 222 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.

Table of Contents

  • I. REPORT FOCUS
  • A. INTRODUCTION
  • CARDIOLOGY
  • KINDS OF CARDIAC CONDITIONS
  • A. BLOOD FLOW IN THE HEART
  • B. HEART MALFUNCTION
  • TYPES OF CARDIAC ARREST
  • C. MYOCARDIUM
  • DISORDERS OF MYOCARDIUM
  • D. PERICARDIUM
  • E. HEART VALVES
  • DISORDERS OF HEART VALVES
  • F. CONGENITAL HEART DEFECT
  • TYPES OF CONGENITAL HEART DEFECT
  • G. AILMENTS OF BLOOD VESSELS (VASCULAR DISEASES)
  • H. HEART FAILURE
  • B. CARDIOVASCULAR DEVICES
  • DEVICES FOR ENDOVASCULAR ANEURYSM REPAIR AND REPLACEMENT
  • TECHNIQUES TO PREVENT CORONARY BLOOD VESSEL SYNDROME
  • TOOLS DEPLOYED IN CARDIOLOGY
  • DIAGNOSTIC TESTS AND PROCEDURES
  • CONCLUSION
  • C. INTERVENTIONAL CARDIOLOGY
  • A. INTERVENTIONAL DIAGNOSTICS AND ITS TECHNOLOGIES
  • I. INTRAVENOUS ULTRASOUND (IVUS)
  • II. OPTICAL COHERENCE TOMOGRAPHY (OCT)
  • III. FRACTIONAL FLOW RESERVE (FFR) - A BIG TECHNOLOGICAL BREAKTHROUGH
  • IMPLICATIONS OF FFR GROWTH - FALL IN USE OF GUIDEWIRES AND DES IN PATIENTS WITH MULTIVESSEL STENOSES
  • FFR HAS GREATER IMPACT ON THE GLOBAL MARKET IN THE LONG TERM
  • EMERGING RIVAL TECHNOLOGIES: CT-FFR AND IFR
  • THE RESULTS OF A CLINICAL TRIAL COMPARING IFR TO FFR
  • PERCUTANEOUS CORONARY INTERVENTION (PCI)
  • B. INTERVENTIONAL CARDIAC DEVICES
  • CORONARY STENTS
  • ADVANCES IN STENT TECHNOLOGY: EXPECTATIONS AND NEW DEVELOPMENTS
  • STENT SCAFFOLD STRUCTURE
  • CORONARY STENT COATING TYPES - IN BRIEF
  • TYPES OF STENT COATINGS, IN BRIEF:-
  • A. INORGANIC COATINGS
  • GOLD
  • SILICON CARBIDE
  • IRIDIUM OXIDE
  • CARBON
  • TITANIUM-NITRIDE-OXIDE
  • B. POLYMER COATINGS
  • NON-BIODEGRADABLE POLYMERS
  • BIODEGRADABLE POLYMERS
  • C. NON-POLYMER COATINGS/SURFACES:
  • MICROPOROUS SURFACES
  • MICROSTRUCTURED SURFACES
  • SLOTTED TUBULAR SURFACES
  • NANOPOROUS SURFACES
  • NPS
  • NANO-PATTERNED SURFACES
  • D. OTHER COATINGS/STRATEGIES
  • HEPARIN
  • HYALURONIC ACID (HA)
  • FIBRIN
  • ENDOTHELIAL CELLS (EC)
  • CONCLUSION
  • CARDIAC STENT USAGE IN THE US
  • PROCEDURES PERFORMED
  • PREFERRED STENT TYPE
  • STENT FACTORS AND THE IMPORTANCE OF VENDOR RELATIONSHIPS
  • A. DRUG-ELUTING STENTS (DES)
  • DIAGNOSTICS LIKELY TO CHANGE DES USAGE
  • INTRAVENOUS DIAGNOSTICS: THE FUTURE GATEKEEPER FOR STENT USAGE
  • DES: THE NEXT TARGET FOR MEDICAL SPENDING CUTS
  • DES AT THE FOREFRONT OF PRICE CUTS AND USAGE LIMITATION
  • ASIAN-BORN INNOVATION TO TARGET A DECLINING DES MARKET IN FUTURE
  • THE BEST STENTS AVAILABLE IN MARKET AND INNOVATIONS ARE ON THE WAY
  • GROWTH TREND OF ASIAN COMPANIES COMPARABLE TO US COMPANIES' IN THE LATE 90'S
  • US AND JAPAN BREAKDOWN OF PCI CASES
  • GLOBAL DRUG-ELUTING STENT MARKET LIKELY TO DECLINE
  • NEXT GENERATION STENTS - BVS, SYNERGY, TCD-10023 AND BIOFREEDOM
  • FIRST-GENERATION STENTS
  • SECOND-GENERATION STENTS
  • THIRD-GENERATION STENTS
  • B. BARE METAL STENTS (BMS)
  • BARE-METAL AND DRUG-ELUTING STENTS MARKET
  • C. ABSORBABLE STENTS/BIODEGRADABLE METALLIC STENT
  • BIOABSORBABLE STENT SCAFFOLDS
  • SELF-EXPANDING STENT SCAFFOLDS
  • MICROMESH COVERED STENT
  • DEDICATED BIFURCATION STENTS
  • SPECULATION ON BIO-ABSORBABLE STENTS
  • D. ANTI-RESTENOSIS DEVICES
  • VASCULAST™ - DRUG ELUTING COATING
  • COVIDIEN COMMENCES PATIENT ENROLMENT IN ANTI-RESTENOSIS STUDY
  • DRUG ELUTING BALLOONS
  • CONCLUSION
  • NEW DIRECTIONS FOR STENT TECHNOLOGY
  • STRONG GROWTH EXPECTED FOR BIOABSORABLE STENTS IN EUROPE, UNITED STATES
  • BIOSENSORS, ABBOTT, ART EMERGE AS BIOABSORABLE STENT COMPETITORS
  • BIFURCATED STENTS TO ENTER THE U.S. MARKET, EUROPEAN MARKET SEES DOUBLE DIGIT GROWTH
  • D. CORONARY STENTS - TYPES & STENT COATING - MARKET BRIEFING
  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • LATIN AMERICA
  • REST OF WORLD
  • II. MARKET ANALYSIS
  • CORONARY STENTS - INDUSTRY SNAPSHOT
  • A. CORONARY STENTS - SEGMENTATION
  • CORONARY STENTS - GLOBAL
  • CORONARY STENTS - BY GEOGRAPHY
  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • LATIN AMERICA
  • REST OF WORLD
  • CORONARY STENTS - BY TYPE
  • CORONARY STENTS - TYPE - BY GEOGRAPHY
  • DRUG-ELUTING STENTS (DES)
  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • LATIN AMERICA
  • REST OF WORLD
  • BARE METAL STENTS (BMS)
  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • LATIN AMERICA
  • REST OF WORLD
  • ABSORBABLE STENTS
  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • LATIN AMERICA
  • REST OF WORLD
  • ANTI-RESTENOSIS DEVICES
  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • LATIN AMERICA
  • REST OF WORLD
  • CORONARY STENTS - BY STENT COATING
  • CORONARY STENTS - STENT COATING - BY GEOGRAPHY
  • INORGANIC
  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • LATIN AMERICA
  • REST OF WORLD
  • POLYMER
  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • LATIN AMERICA
  • REST OF WORLD
  • NON-POLYMER
  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • LATIN AMERICA
  • REST OF WORLD
  • OTHER STENT COATINGS
  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • LATIN AMERICA
  • REST OF WORLD
  • B. GROWTH RATE ANALYSIS
  • GLOBAL CORONARY STENTS - MARKET GROWTH RATES
  • GLOBAL CORONARY STENTS - TYPE - GROWTH RATES
  • GLOBAL CORONARY STENTS - STENT COATING - GROWTH RATES
  • C. INVESTMENT FOCUS
  • III. INDUSTRY OVERVIEW
  • FREQUENT OCCURRENCES OF CARDIOVASCULAR DISEASES WITNESS IMPROVEMENTS IN MEDICAL DEVICES FOR CARDIOVASCULAR APPLICATIONS
  • AN ENCOURAGING JAB FOR TORPID PERIODS
  • A. A REVIEW ON CARDIAC MEDICAL DEVICE TYPES
  • CARDIAC RHYTHM MANAGEMENT DEVICES
  • CRM IN EUROPE
  • CARDIAC DEFIBRILLATORS
  • RAPID GROWTH IN DEFIBRILLATOR SALES
  • CARDIAC PACEMAKER DEVICES
  • THE DATA COLLECTION WORK
  • CARDIAC RESYNCHRONIZATION THERAPY (CRT)
  • CARDIAC MONITORING AND DIAGNOSTIC DEVICES
  • THE PROGRESSIVE AND FREQUENT OCCURRENCES OF HEART DISEASES TO ENCOURAGE HUGE DEMAND OF DIAGNOSTIC CARDIAC MONITORING SYSTEMS
  • INCORPORATION OF SYSTEMS WITH EMR TO BOOST EXTENDED GROWTH OF MARKET
  • THE NORTH AMERICAN CARDIAC MONITORING DEVICES MARKET OVERVIEW
  • INTERVENTIONAL CARDIAC DEVICES
  • CORONARY STENTS
  • EVOLUTION OF STENT TECHNOLOGY ATTRACTS HUGE ATTENTION
  • FFR IMPACT ON DES MARKET
  • MARKET FORECASTS AN IMPACT OF FFR AND OCT ON THE DES MARKET
  • CARDIAC CATHETERS
  • COMPETITIVE ANALYSIS
  • ELECTROPHYSIOLOGY CATHETERS (EP)
  • GROWTH IN ELECTROPHYSIOLOGISTS IN EUROPE
  • DIAGNOSTIC EP CATHETERS, ABLATION DEVICES SEE STRONG INDUSTRY GROWTH
  • EP MAPPING
  • NEW AF ABLATION DEVICES SEEK APPROVAL
  • ATRIAL FIBRILLATION (AF)
  • INTRAVASCULAR ULTRASOUND (IVUS)
  • GO WITH THE FLOW: FRACTIONAL FLOW RESERVE, THAT IS
  • PERIPHERAL VASCULAR DEVICES
  • ARTERIOTOMY CLOSURE DEVICES
  • EMBOLIC PROTECTION DEVICES (EPD)
  • INFERIOR VENA CAVA (IVC) FILTERS
  • CONCLUSION
  • PERIPHERAL GUIDEWIRES
  • AV ACCESS THROMBECTOMY DEVICES
  • PROSTHETIC HEART VALVES
  • SWISS CARDIOVASCULAR DEVICES: A MARKET REVIEW
  • MARKET CHALLENGES
  • B. CARDIAC DEVICES: MORTALITY RISKS V/S AGE
  • DRIVERS IN THE MEDICAL IMPLANT INDUSTRY
  • SIZE AND WEIGHT
  • POWER EFFICIENCY
  • PERFORMANCE SPECIFICATIONS
  • RISK MITIGATION AND RELIABILITY
  • EXCITING FUTURE PREDICTED FOR ADVANCED CARDIOVASCULAR DEVICES
  • C. CARDIAC DISEASE: AN ECONOMIC PERSPECTIVE
  • CARDIOVASCULAR DISEASE (CVD) AND ITS EFFECTS ON HEALTH AND ECONOMY
  • IMPACT OF CVD IN EUROPE
  • IMPACT ON NEW YORK STATE
  • ECONOMIC IMPACT OF CVD IN NYS
  • HEALTH AND ECONOMIC IMPACT OF HEART DISEASE PREVENTION
  • IMPACT OF CVD ON ECONOMIC STABILITY
  • ECONOMIC COST OF CARDIOVASCULAR DISEASES
  • COST OF CARDIOVASCULAR DISEASE TO TRIPLE BY 2030
  • CARDIOVASCULAR DISEASE IS LARGELY PREVENTABLE
  • D. INFECTIOUS AND CARDIOVASCULAR DISEASES IN AFRICA AND BEYOND
  • E. RECENT FDA ACTIONS AND APPROVALS IN CARDIOVASCULAR DEVICES
  • F. MARKET TRENDS
  • PATIENT ENROLLMENT BY CARDIAC DIMENSIONS IN TITAN II CLINICAL TRIAL
  • CEDARS-SINAI HEART INSTITUTE STUDY: STEM CELLS AUGMENTS HEART'S NATURAL REPAIR SYSTEMS
  • GE HEALTHCARE'S DISCOVERY IGS 730 SYSTEM, AN INNOVATION FOR HYBRID OPERATING ROOMS
  • GE'S AUTOMATED FUNCTION IMAGING FOR DAILY CLINICAL USE.
  • CRYOLIFE RECEIVES EXPANDED INDICATION FOR BIOFOAM IN CARDIOVASCULAR SURGERIES IN EUROPE
  • INNOVATIVE PROCEDURES TO TREAT PERIPHERAL ARTERY DISEASE (PAD)
  • TASK FORCE® MONITOR DEMONSTRATED AS EFFECTIVE AUTONOMIC BIOMARKER IN CFS PATIENTS
  • INNOVATION IN INTERVENTIONAL CARDIOLOGY: CATHETER RETRIEVAL OF INFECTIVE FLORA AND MOVABLE CLOTS FROM CARDIAC VALVES AND COMPARTMENTS
  • STEREO-TAXIS UNVEILS LATEST ELECTROPHYSIOLOGY PLATFORM: EPOCH (TM)
  • VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING
  • VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING
  • STEREO TAXIS REPORTS DEVELOPMENT OF CATHETER STRATEGIC AFFILIATION
  • GLP PRE-MEDICAL STUDIES EXHIBIT NCONTACT ABLATION LESIONS ARE COMPREHENSIVE AND TRANSMURAL
  • MODERNIZATIONS IN INTERVENTIONAL CARDIOLOGY: TECHNOLOGY, FINANCES AND POLITICAL POLICIES
  • B. BRAUN'S INTROCAN SAFETY® 3 CLOSED IV CATHETER IS PRESENTED WITH TOP INNOVATION AWARD
  • MID SECURES FIRST TRANCHE OF $5 MILLION SERIES B FINANCING
  • RESEARCH REVEALS THAT HUMAN HEARTS PRODUCES NEW CELLS AFTER BIRTH
  • A NEW TYPE OF NERVE CELL IDENTIFIED IN THE BRAIN
  • ROCHE TO ADVANCE 240 MILLION SWISS FRANCS IN DIAGNOSTICS PRODUCTION IN GERMANY
  • SORIN GROUP ANNOUNCES INVESTMENT IN HIGHLIFE.
  • FIRST 34 U.S. PATIENTS IMPLANTED WITH BIOTRONIK'S NEW EVIA HF-T PACEMAKER.
  • AORTECH LNTERNATIONAL PLC CLAIMS MATERIAL BREACH OF CONTRACT BY DIVISION OF ST. JUDE MEDICAL
  • SPECTRANETICS LAUNCHES U.S COMMENCEMENT OF THE TAPAS(TM) CATHETER AND PRECLINICAL ANIMAL DATA ON DRUG UPTAKE IN PERIPHERAL VESSELS
  • USCOM MAKES PRESENTATIONS AT WORLD HYPERTENSION CONGRESS
  • MORTARA INSTRUMENT, INC. LAUNCHES "BUILT WITH PRIDE IN MILWAUKEE" CAMPAIGN.
  • MALLINCKRODT JOINS PARTNERSHIP AT DRUGFREE.ORG TO INTRODUCE MEDICINE ABUSE PROJECT
  • DRUG-ELUTING STENTS ARE SECURE
  • CARDIAC SCIENCE BEGS TOP RANKING MD BUYLINE'S USER SATISFACTION SURVEY
  • ARTIFICIAL HEART SUCCESSFULLY IMPLANTED IN A BABY IN JAPAN FOR THE FIRST TIME
  • ARTERIAL REMODELING TECHNOLOGIES ANNOUNCES FIRST HUMAN USE OF ITS NEXT-GENERATION BIORESORBABLE STENT
  • ATRIUM MEDICAL CORPORATION RECEIVES PREMIER PERFORMANCE AWARD FOR OPERATIONAL EXCELLENCE.
  • BAYER HEALTHCARE DISCLOSES ADVANCES IN CT CONTRAST DOSE MANAGEMENT™ SOLUTIONS.
  • HRS: REMOTE PATIENT MONITORING TO MINIMIZE UNPLANNED ED ADMINS
  • FUTURE HOME HEALTH CARE EQUIPMENT TREND- TECHNOLOGY OUTLOOK
  • FORTUNE MAGAZINE NAMED ST. JUDE MEDICAL AS THE "MOST ADMIRED COMPANY"
  • BIOTRONIK OPENS NEW ASIA PACIFIC HEADQUARTERS IN SINGAPORE
  • COOK MEDICAL TO INVEST €16.5M IN IRISH MEDICAL TECHNOLOGY MARKET
  • MAJOR EVENTS IN CARDIOVASCULAR MEDICAL DEVICE SPACE
  • MEDICAL IMAGING EQUIPMENT OF SIEMENS HEALTHCARE WINS LARGEST ORDER IN LATIN AMERICA.
  • NEGATIVE TRENDS IN INNOVATION IN INTERVENTIONAL CARDIOLOGY DESPITE DECREASES IN CVD MORTALITY-INTERVENTIONAL CARDIOLOGISTS EXPRESS ANGUISH
  • FIRST IMPLANT OF BOSTON SCIENTIFIC'S WATCHMAN® DEVICE IN PATIENTS IN LATIN AMERICA
  • STUDY REVEALS THAT BAYER HEALTHCARE'S COTAVANCE® DRUG ELUTING BALLOONS WITH PACCOCATH® TECHNOLOGY REDUCED TARGET LESION REVASCULARIZATION (TLR) RATES BY 59% IN PAD PATIENTS COMPARED TO THOSE TREATED WITH UNCOATED BALLOONS.
  • USCOM PRESENTED NEW HYPERTENSION MANAGEMENT STUDY AT WORLD HYPERTENSION CONGRESS
  • SAHAJANAND MEDICAL TECHNOLOGIES AWARDED MEDICAL DEVICE COMPANY OF THE YEAR 2011
  • TERUMO CORPORATION, A WELL KNOWN PIONEER IN MEDICAL DEVICE TECHNOLOGY, CELEBRATES 90TH ANNIVERSARY
  • CARDICA ACHIEVES LANDMARK UNDER DISTRIBUTION AGREEMENT WITH CENTURY MEDICAL
  • SOLUTIONS FOR SUSTAINABLE CARDIOVASCULAR CARE AT THE EUROPEAN SOCIETY OF CARDIOLOGY (ESC)
  • EXCOR® PEDIATRIC VENTRICULAR ASSIST DEVICE RECOMMENDED BY FDA ADVISORY PANEL FOR USE IN THE UNITED STATES.
  • ZOLL NOMINATED TO GLOBE 100 AGAIN
  • USCOM ENTERS EUROPEAN MARKETS
  • POSITIVE GROWTH AND OUTLOOK FOR BIOTRONIK IN USA AND OTHER MARKETS
  • USCOM SECURES STRONG PRESENCE IN US AND CANADA
  • CARDIOMEMS AMONG THE TOP 10 INNOVATIVE TECHNOLOGY COMPANIES
  • COVIDIEN INTRODUCES NEW GLOBAL PACKAGING
  • STENTYS'S DRUG-ELUTING STENT RECEIVES MORE REIMBURSEMENT IN GERMANY.
  • SORIN GROUP INTRODUCES THE ACHIEVEMENT OF A KEY MILESTONE IN AORTIC VALVE REPLACEMENT
  • CARDIOMEMS RECEIVES GEORGIA BIO (GABIO) 2011 DEAL OF THE YEAR AWARD
  • USCOM EYES EASTERN EUROPEAN MARKET
  • VCU SUCCESSFULLY TRANSPLANTED 900TH TOTAL ARTIFICIAL HEART
  • INNOVATIVE TRENDS IN RECENT MEDICAL DEVICES
  • INFECTIONS FROM IMPLANTED CARDIAC DEVICES
  • TYRX REACHES MILESTONE IN AIGISRX IMPLANTATION
  • HEART TRANSPLANTS SUBSTITUTED BY A PUMP
  • DEVICES FOR TREATMENT OF ATRIAL FIBRILLATIONS (AF)
  • REMOTE MONITORING OF HEART FAILURE PATIENTS
  • EFFECTS OF REMOTE MONITORING OF IMPLANTED DEVICES
  • OAKWOOD HOSPITAL AND WAYNE STATE UNIVERSITY WORKING ON HEART IMPLANTATION
  • IMPLANTABLE CARDIAC MONITOR WITH HELPFUL APPROACH
  • OVER-THE-COUNTER APPARATUS
  • BOSTON SCIENTIFICS' IMPLANTABLE DEFIBRILLATOR
  • CARDIAC SCIENCE'S NEW CARDIAC TREATMENT
  • THE ONLY SYNCHRONIZED SURGICAL AND CATHETER BASED ATRIAL FIBRILLATION
  • CARDIAC SCIENCE CORPORATION WITH CARDIAC DISEASES HEALING METHOD
  • LOCAL MEDICARE'S COVERAGE FOR HYPERTENSION WITH BIOZ(R) ICG TECHNOLOGY
  • A NEW STANDARD IN CARDIAC SPECT RECONSTRUCTION
  • A REVOLUTIONIZED ELECTROPHYSIOLOGY (EP) FOR CARDIAC
  • LIDCO PRODUCTS ACCEPTED IN SOUTH KOREA
  • INVENTION OF BI-DIRECTIONAL CARDIAC CATHETER FOR IRREGULAR HEART RHYTHMS
  • BEST AND LATEST SELF-TEACHING HEART SOUNDS
  • REPLACING VALVE WITHOUT CARDIAC SUPPORT
  • U.S. FDA GRANTS THE NAVISTAR® THERMOCOOL CATHETER FOR RAPID HEART BEAT
  • AN FDA US APPROVED TREATMENT FOR CLOGGED NECK ARTERIES
  • NEW-FANGLED SPECIALTY CATHETER BY ABBOTT AT THE USA
  • MEDICAL IMPLANT MARKETS UNDER THE INFLUENCE OF TECHNICAL TRENDS
  • G. KEY COMPANY PROFILES
  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • REST OF WORLD
  • OTHER KEY COMPANY INDUSTRY ACTIVITES / PRODUCT LAUNCHES
  • CARDIAC DEVICES MARKETED AND PIPELINE PRODUCTS
  • CARDIAC MEDICAL DEVICES - PATENTS
  • KEY COMPANIES FINANCIAL OVERVIEW
  • IV. INDUSTRY COMPANY DATABASE
  • V. APPENDIX
  • RESEARCH FOCUS
  • ABOUT AXIS RESEARCH MIND
  • DISCLAIMER
  • FEEDBACK

LIST OF TABLES/CHARTS

  • I. REPORT FOCUS
  • 1. COMPARISON PCI GUIDELINE IN US AND EU FOR IVUS/OCT/FFR
  • 2. LIST OF DEDICATED CORONARY BIFURCATION STENTS
  • 3. CURRENTLY AVAILABLE BARE-METAL CORONARY STENT SYSTEMS
  • 4. BIOABSORBABLE SCAFFOLDS (ADVANTAGES AND DISADVANTAGES)
  • 5. LIST OF BIOABSORBABLE STENTS WITH CHARACTERISTICS AND CLINICAL EVIDENCE
  • 6. CONTEMPORARY DRUG ELUTING BALLOONS
  • D. CORONARY STENTS - TYPES & STENT COATING - MARKET BRIEFING
  • NORTH AMERICA
  • 7. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR NORTH AMERICA - (2012-2018, IN USD$ MILLION)
  • 8. CORONARY STENTS TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF NORTH AMERICA MARKET VALUE - (2015 - 2018)
  • 9. CORONARY STENTS - STENT COATING MARKET - INORGANIC, POLYMER, NON-POLYMER AND OTHER STENT COATINGS FOR NORTH AMERICA - (2012-2018, IN USD$ MILLION)
  • 10. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER STENT COATINGS - % OF NORTH AMERICA MARKET VALUE - (2015 - 2018)
  • EUROPE
  • 11. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR EUROPE - (2012-2018, IN USD$ MILLION)
  • 12. CORONARY STENTS TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF EUROPEAN MARKET VALUE - (2015 - 2018)
  • 13. CORONARY STENTS - STENT COATING MARKET - INORGANIC, POLYMER, NON-POLYMER AND OTHER STENT COATINGS FOR EUROPE - (2012-2018, IN USD$ MILLION)
  • 14. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER STENT COATINGS - % OF EUROPEAN MARKET VALUE - (2015 - 2018)
  • ASIA-PACIFIC
  • 15. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)
  • 16. CORONARY STENTS TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF ASIA-PACIFIC MARKET VALUE - (2015 - 2018)
  • 17. CORONARY STENTS - STENT COATING MARKET - INORGANIC, POLYMER, NON-POLYMER AND OTHER STENT COATINGS FOR ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)
  • 18. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER STENT COATINGS - % OF ASIA-PACIFIC MARKET VALUE - (2015 - 2018)
  • LATIN AMERICA
  • 19. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR LATIN AMERICA - (2012-2018, IN USD$ MILLION)
  • 20. CORONARY STENTS TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF LATIN AMERICA MARKET VALUE - (2015 - 2018)
  • 21. CORONARY STENTS - STENT COATING MARKET - INORGANIC, POLYMER, NON-POLYMER AND OTHER STENT COATINGS FOR LATIN AMERICA - (2012-2018, IN USD$ MILLION)
  • 22. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER STENT COATINGS - % OF LATIN AMERICA MARKET VALUE - (2015 - 2018)
  • REST OF WORLD
  • 23. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 24. CORONARY STENTS TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF REST OF WORLD MARKET VALUE - (2015 - 2018)
  • 25. CORONARY STENTS - STENT COATING MARKET - INORGANIC, POLYMER, NON-POLYMER AND OTHER STENT COATINGS FOR REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 26. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER STENT COATINGS - % OF REST OF WORLD MARKET VALUE - (2015 - 2018)
  • 27. CORONARY STENTS - PRODUCT BY BRANDS
  • II. MARKET ANALYSIS
  • 28. GLOBAL CORONARY STENTS - SEGMENTATION BY TYPE
  • CORONARY STENTS - GLOBAL
  • 29. CORONARY STENTS MARKET - GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2012-2018, IN USD$ MILLION)
  • 30. CORONARY STENTS MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 31. CORONARY STENTS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2015-2018)
  • CORONARY STENTS - BY GEOGRAPHY
  • NORTH AMERICA
  • 32. CORONARY STENTS MARKET - USA AND CANADA - (2012-2018, IN USD$ MILLION)
  • 33. CORONARY STENTS - % OF USA AND CANADA MARKET VALUE - (2015-2018)
  • EUROPE
  • 34. CORONARY STENTS MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE - (2012-2018, IN USD$ MILLION)
  • 35. CORONARY STENTS - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE MARKET VALUE - (2015-2018)
  • ASIA-PACIFIC
  • 36. CORONARY STENTS MARKET - JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)
  • 37. CORONARY STENTS - % OF JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC MARKET VALUE - (2015-2018)
  • LATIN AMERICA
  • 38. CORONARY STENTS MARKET - BRAZIL, ARGENTINA AND REST OF LATIN AMERICA - (2012-2018, IN USD$ MILLION)
  • 39. CORONARY STENTS - % OF BRAZIL, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2015-2018)
  • REST OF WORLD
  • 40. CORONARY STENTS MARKET - SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 41. CORONARY STENTS - % OF SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD MARKET VALUE - (2015-2018)
  • CORONARY STENTS - BY TYPE
  • 42. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2012-2018, IN USD$ MILLION)
  • 43. CORONARY STENTS - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF GLOBAL MARKET VALUE - (2015-2018)
  • CORONARY STENTS - TYPE - BY GEOGRAPHY
  • DRUG-ELUTING STENTS (DES)
  • 44. DRUG-ELUTING STENTS (DES) MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 45. DRUG-ELUTING STENTS (DES) - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2015-2018)
  • NORTH AMERICA
  • 46. DRUG-ELUTING STENTS (DES) MARKET - USA AND CANADA - (2012-2018, IN USD$ MILLION)
  • 47. DRUG-ELUTING STENTS (DES) - % OF USA AND CANADA MARKET VALUE - (2015-2018)
  • EUROPE
  • 48. DRUG-ELUTING STENTS (DES) MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE - (2012-2018, IN USD$ MILLION)
  • 49. DRUG-ELUTING STENTS (DES) - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE MARKET VALUE - (2015-2018)
  • ASIA-PACIFIC
  • 50. DRUG-ELUTING STENTS (DES) MARKET - JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)
  • 51. DRUG-ELUTING STENTS (DES) - % OF JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC MARKET VALUE - (2015-2018)
  • LATIN AMERICA
  • 52. DRUG-ELUTING STENTS (DES) MARKET - BRAZIL, ARGENTINA AND REST OF LATIN AMERICA - (2012-2018, IN USD$ MILLION)
  • 53. DRUG-ELUTING STENTS (DES) - % OF BRAZIL, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2015-2018)
  • REST OF WORLD
  • 54. DRUG-ELUTING STENTS (DES) MARKET - SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 55. DRUG-ELUTING STENTS (DES) - % OF SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD MARKET VALUE - (2015-2018)
  • BARE METAL STENTS (BMS)
  • 56. BARE METAL STENTS (BMS) MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 57. BARE METAL STENTS (BMS) - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2015-2018)
  • NORTH AMERICA
  • 58. BARE METAL STENTS (BMS) MARKET - USA AND CANADA - (2012-2018, IN USD$ MILLION)
  • 59. BARE METAL STENTS (BMS) - % OF USA AND CANADA MARKET VALUE - (2015-2018)
  • EUROPE
  • 60. BARE METAL STENTS (BMS) MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE - (2012-2018, IN USD$ MILLION)
  • 61. BARE METAL STENTS (BMS) - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE MARKET VALUE - (2015-2018)
  • ASIA-PACIFIC
  • 62. BARE METAL STENTS (BMS) MARKET - JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)
  • 63. BARE METAL STENTS (BMS) - % OF JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC MARKET VALUE - (2015-2018)
  • LATIN AMERICA
  • 64. BARE METAL STENTS (BMS) MARKET - BRAZIL, ARGENTINA AND REST OF LATIN AMERICA - (2012-2018, IN USD$ MILLION)
  • 65. BARE METAL STENTS (BMS) - % OF BRAZIL, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2015-2018)
  • REST OF WORLD
  • 66. BARE METAL STENTS (BMS) MARKET - SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 67. BARE METAL STENTS (BMS) - % OF SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD MARKET VALUE - (2015-2018)
  • ABSORBABLE STENTS
  • 68. ABSORBABLE STENTS MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 69. ABSORBABLE STENTS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2015-2018)
  • NORTH AMERICA
  • 70. ABSORBABLE STENTS MARKET - USA AND CANADA - (2012-2018, IN USD$ MILLION)
  • 71. ABSORBABLE STENTS - % OF USA AND CANADA MARKET VALUE - (2015-2018)
  • EUROPE
  • 72. ABSORBABLE STENTS MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE - (2012-2018, IN USD$ MILLION)
  • 73. ABSORBABLE STENTS - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE MARKET VALUE - (2015-2018)
  • ASIA-PACIFIC
  • 74. ABSORBABLE STENTS MARKET - JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)
  • 75. ABSORBABLE STENTS - % OF JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC MARKET VALUE - (2015-2018)
  • LATIN AMERICA
  • 76. ABSORBABLE STENTS MARKET - BRAZIL, ARGENTINA AND REST OF LATIN AMERICA - (2012-2018, IN USD$ MILLION)
  • 77. ABSORBABLE STENTS - % OF BRAZIL, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2015-2018)
  • REST OF WORLD
  • 78. ABSORBABLE STENTS MARKET - SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 79. ABSORBABLE STENTS - % OF SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD MARKET VALUE - (2015-2018)
  • ANTI-RESTENOSIS DEVICES
  • 80. ANTI-RESTENOSIS DEVICES MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 81. ANTI-RESTENOSIS DEVICES - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2015-2018)
  • NORTH AMERICA
  • 82. ANTI-RESTENOSIS DEVICES MARKET - USA AND CANADA - (2012-2018, IN USD$ MILLION)
  • 83. ANTI-RESTENOSIS DEVICES - % OF USA AND CANADA MARKET VALUE - (2015-2018)
  • EUROPE
  • 84. ANTI-RESTENOSIS DEVICES MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE - (2012-2018, IN USD$ MILLION)
  • 85. ANTI-RESTENOSIS DEVICES - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE MARKET VALUE - (2015-2018)
  • ASIA-PACIFIC
  • 86. ANTI-RESTENOSIS DEVICES MARKET - JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)
  • 87. ANTI-RESTENOSIS DEVICES - % OF JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC MARKET VALUE - (2015-2018)
  • LATIN AMERICA
  • 88. ANTI-RESTENOSIS DEVICES MARKET - BRAZIL, ARGENTINA AND REST OF LATIN AMERICA - (2012-2018, IN USD$ MILLION)
  • 89. ANTI-RESTENOSIS DEVICES - % OF BRAZIL, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2015-2018)
  • REST OF WORLD
  • 90. ANTI-RESTENOSIS DEVICES MARKET - SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 91. ANTI-RESTENOSIS DEVICES - % OF SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD MARKET VALUE - (2015-2018)
  • CORONARY STENTS - BY STENT COATING
  • 92. CORONARY STENTS - STENT COATING MARKET - INORGANIC, POLYMER, NON-POLYMER AND OTHER STENT COATINGS FOR GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2012-2018, IN USD$ MILLION)
  • 93. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS - % OF GLOBAL MARKET VALUE - (2015-2018)
  • CORONARY STENTS - STENT COATING - BY GEOGRAPHY
  • INORGANIC
  • 94. INORGANIC MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 95. INORGANIC - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2015-2018)
  • NORTH AMERICA
  • 96. INORGANIC MARKET - USA AND CANADA - (2012-2018, IN USD$ MILLION)
  • 97. INORGANIC - % OF USA AND CANADA MARKET VALUE - (2015-2018)
  • EUROPE
  • 98. INORGANIC MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE - (2012-2018, IN USD$ MILLION)
  • 99. INORGANIC - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE MARKET VALUE - (2015-2018)
  • ASIA-PACIFIC
  • 100. INORGANIC MARKET - JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)
  • 101. INORGANIC - % OF JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC MARKET VALUE - (2015-2018)
  • LATIN AMERICA
  • 102. INORGANIC MARKET - BRAZIL, ARGENTINA AND REST OF LATIN AMERICA - (2012-2018, IN USD$ MILLION)
  • 103. INORGANIC - % OF BRAZIL, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2015-2018)
  • REST OF WORLD
  • 104. INORGANIC MARKET - SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 105. INORGANIC - % OF SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD MARKET VALUE - (2015-2018)
  • POLYMER
  • 106. POLYMER MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 107. POLYMER - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2015-2018)
  • NORTH AMERICA
  • 108. POLYMER MARKET - USA AND CANADA - (2012-2018, IN USD$ MILLION)
  • 109. POLYMER - % OF USA AND CANADA MARKET VALUE - (2015-2018)
  • EUROPE
  • 110. POLYMER MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE - (2012-2018, IN USD$ MILLION)
  • 111. POLYMER - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE MARKET VALUE - (2015-2018)
  • ASIA-PACIFIC
  • 112. POLYMER MARKET - JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)
  • 113. POLYMER - % OF JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC MARKET VALUE - (2015-2018)
  • LATIN AMERICA
  • 114. POLYMER MARKET - BRAZIL, ARGENTINA AND REST OF LATIN AMERICA - (2012-2018, IN USD$ MILLION)
  • 115. POLYMER - % OF BRAZIL, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2015-2018)
  • REST OF WORLD
  • 116. POLYMER MARKET - SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 117. POLYMER - % OF SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD MARKET VALUE - (2015-2018)
  • NON-POLYMER
  • 118. NON-POLYMER MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 119. NON-POLYMER - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2015-2018)
  • NORTH AMERICA
  • 120. NON-POLYMER MARKET - USA AND CANADA - (2012-2018, IN USD$ MILLION)
  • 121. NON-POLYMER - % OF USA AND CANADA MARKET VALUE - (2015-2018)
  • EUROPE
  • 122. NON-POLYMER MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE - (2012-2018, IN USD$ MILLION)
  • 123. NON-POLYMER - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE MARKET VALUE - (2015-2018)
  • ASIA-PACIFIC
  • 124. NON-POLYMER MARKET - JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)
  • 125. NON-POLYMER - % OF JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC MARKET VALUE - (2015-2018)
  • LATIN AMERICA
  • 126. NON-POLYMER MARKET - BRAZIL, ARGENTINA AND REST OF LATIN AMERICA - (2012-2018, IN USD$ MILLION)
  • 127. NON-POLYMER - % OF BRAZIL, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2015-2018)
  • REST OF WORLD
  • 128. NON-POLYMER MARKET - SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 129. NON-POLYMER - % OF SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD MARKET VALUE - (2015-2018)
  • OTHER STENT COATINGS
  • 130. OTHER STENT COATINGS MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 131. OTHER STENT COATINGS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2015-2018)
  • NORTH AMERICA
  • 132. OTHER STENT COATINGS MARKET - USA AND CANADA - (2012-2018, IN USD$ MILLION)
  • 133. OTHER STENT COATINGS - % OF USA AND CANADA MARKET VALUE - (2015-2018)
  • EUROPE
  • 134. OTHER STENT COATINGS MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE - (2012-2018, IN USD$ MILLION)
  • 135. OTHER STENT COATINGS - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE MARKET VALUE - (2015-2018)
  • ASIA-PACIFIC
  • 136. OTHER STENT COATINGS MARKET - JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC - (2012-2018, IN USD$ MILLION)
  • 137. OTHER STENT COATINGS - % OF JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC MARKET VALUE - (2015-2018)
  • LATIN AMERICA
  • 138. OTHER STENT COATINGS MARKET - BRAZIL, ARGENTINA AND REST OF LATIN AMERICA - (2012-2018, IN USD$ MILLION)
  • 139. OTHER STENT COATINGS - % OF BRAZIL, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2015-2018)
  • REST OF WORLD
  • 140. OTHER STENT COATINGS MARKET - SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 141. OTHER STENT COATINGS - % OF SOUTH AFRICA, MIDDLE EAST AND REST OF REST OF WORLD MARKET VALUE - (2015-2018)
  • B. GROWTH RATE ANALYSIS
  • GLOBAL CORONARY STENTS - MARKET GROWTH RATES
  • 142. CORONARY STENTS MARKET - GEOGRAPHIC REGION - % GROWTH RATE FORECASTS - (2012-2018)
  • GLOBAL CORONARY STENTS - TYPE - GROWTH RATES
  • 143. CORONARY STENTS - TYPES - % GROWTH RATE FORECASTS FOR DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - (2012-2018)
  • GLOBAL CORONARY STENTS - STENT COATING - GROWTH RATES
  • 144. CORONARY STENTS - STENT COATING - % GROWTH RATE FORECASTS FOR INORGANIC, POLYMER, NON-POLYMER AND OTHER STENT COATINGS - (2012-2018)
  • C. INVESTMENT FOCUS
  • 145. CORONARY STENTS - FORECASTED CAGR% - 2012-2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND BRAZIL
  • 146. CORONARY STENTS - TYPES - DRUG ELUTING STENTS, BARE METAL STENTS, ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - FORECASTED CAGR% - VALUE - 2012-2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND BRAZIL
  • 147. CORONARY STENTS - COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER & R&D - FORECASTED CAGR% - VALUE - 2012-2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND BRAZIL
  • III. INDUSTRY OVERVIEW
  • 148: INTRAVENOUS DIAGNOSTICS - BY TYPE - FFR - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR USA, JAPAN, EUROPE AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 149: INTRAVENOUS DIAGNOSTICS - BY TYPE - OCT - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR USA, JAPAN, EUROPE AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 150. ESTIMATED DIRECT AND INDIRECT COSTS OF CARDIOVASCULAR DISEASES IN THE UNITED STATES OF AMERICA - (2010, IN USD BILLION)
  • 151. PROJECTED TOTAL COSTS OF CARDIOVASCULAR DISEASES IN THE UNITED STATES OF AMERICA - (2015-2030, IN USD BILLION)
  • 152. ESTIMATED DIRECT AND INDIRECT COSTS OF CARDIOVASCULAR DISEASE BY AGE - (2012, IN USD BILLION)
  • 153. PROJECTIONS OF CRUDE CARDIOVASCULAR DISEASE PREVALENCE - (% - 2010-2030) IN THE UNITED STATES
  • 154. PROJECTED DIRECT MEDICAL COSTS OF CARDIOVASCULAR DISEASE - ($USD BILLION, 2010-2030) IN THE UNITED STATES
  • 155. PROJECTED INDIRECT LOST PRODUCTIVITY COSTS OF CARDIOVASCULAR DISEASE - ($USD BILLION, 2010-2030) IN THE UNITED STATES
  • 156. LIST OF APPROVALS FOR CARDIOVASCULAR MEDICAL DEVICES IN 2014
  • 157. LIST OF APPROVALS FOR CARDIOVASCULAR MEDICAL DEVICES IN 2013
  • 158. WORLDWIDE KEY PLAYERS INTO CARDIOVASCULAR DEVICES INDUSTRY THAT PROJECT IMPROVED MARKET ACTIVITIES IN THE NEAR FUTURE
  • 159. COVERAGE OF CARDIAC DEVICES MARKETED AND PIPELINE PRODUCTS
  • 160. CARDIAC ARRHYTHMIAS DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME
  • 161. CIRCADIAN RHYTHM SLEEP DISORDERS DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME - 2014
  • 162. PERIPHERAL VASCULAR DISEASE (PVD) DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME
  • 163. ANNUAL SALES OF CARDIAC THERAPY PRODUCTS MARKETED BY THERAPY AREA - (2010-2012, IN US$ MILLION)
  • 164. ABIOMED, INC. - PRODUCT REVENUE, FOR 2011-2013 (IN US$ '000)
  • 165. ACCELLENT, INC. - NET REVENUE, FOR 2011 AND 2012 (IN US$ '000)
  • 166. ALERE, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 (IN US$ '000)
  • 167. AMBU A/S, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 & 2013 (IN DKK MILLION)
  • 168. ANGIODYNAMICS, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 & 2013 (IN USD$ '000)
  • 169. ATRICURE, INC. - NET SALES BY PRODUCT IN DOMESTIC & INTERNATIONAL AND GEOGRAPHY, FOR 2012 & 2013 (IN US$ '000)
  • 170. BAXTER INTERNATIONAL, INC. - NET SALES BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 & 2013 (IN USD$ MILLION)
  • 171. BECTON, DICKINSON & CO - NET SALES BY MARKET SEGMENT, FOR 2011-2013 (IN USD$ MILLION)
  • 172. BIOHEART, INC. - NET SALES, FOR 2011-2013 (IN US$ '000)
  • 173. BIOSENSORS INTERNATIONAL GROUP, LTD. - NET SALES REVENUE BY MARKET SEGMENT, LICENSING AND GEOGRAPHY, FOR 2012 & 2013 (IN US$ '000)
  • 174. BIOTELEMETRY, INC. - NET SALES REVENUE AND GROSS PROFIT, FOR 2011-2013 (IN US$ '000)
  • 175. BOSTON SCIENTIFIC CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN USD$ MILLION)
  • 176. C. R. BARD, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 177. CARDICA, INC. - NET REVENUE, FOR 2011-2013 (IN US$ '000)
  • 178. COMPUMED. INC. - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 IN USD
  • 179. COVIDEN, INC. - NET REVENUE BY MARKET SEGMENT & GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 180. COVIDEN, INC. - NET REVENUE BY MARKET SEGMENT, FOR USA AND NON-USA FOR 2011-2013 (IN US$ MILLION)
  • 181. CONMED CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
  • 182. CRYOLIFE, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ '000)
  • 183. CRYOLIFE, INC. - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
  • 184. DELTEX MEDICAL GROUP PLC - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 (IN US$ '000)
  • 185. DIGIRAD CORPORATION - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ '000)
  • 186. DRÄGER MEDICAL AG & CO. KG - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 AND 2013 (IN US$ 'MILLION)
  • 187. EDWARDS LIFESCIENCES LLC - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ 'MILLION)
  • 188. ENDOLOGIX, INC, - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 189. HEARTWARE, LTD. - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
  • 190. HOSPIRA, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 191. INDRAPRASTHA APOLLO HOSPITAL - NET REVENUE, FOR 2012-2013 (IN INDIAN RUPEES)
  • 192. INSPIREMD, LTD. - NET REVENUE, FOR 2012-2013 (IN US$ '000)
  • 193. JOHNSON & JOHNSON - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 194. KONINKLIJKE DSM N.V - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 AND 2013 IN (EURO MILLION)
  • 195. LOMBARD MEDICAL TECHNOLOGIES PLC - NET REVENUE, FOR 2011-2013 (IN US$ '000)
  • 196. OPTO CIRCUITS (INDIA) LIMITED - NET REVENUE BY CONSOLIDATED AND STANDALONE, FOR 2011-2013 (IN INDIAN RUPEES)
  • 197. MICROPORT MEDICAL (SHANGHAI) CO. LTD - NET REVENUE, FOR 2012 AND 2013 SIX MONTHS ENDED 30TH JUNE (IN RMB'000)
  • 198. ST. JUDE MEDICAL, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (US$ IN MILLION)
  • 199. TTK - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN INDIAN RUPEES)
  • 200. CARDIUM THERAPEUTICS, INC. - NET REVENUE, FOR 2012-2013 ENDED FOR NINE MONTHS (IN US$ MILLION)
  • 201. MERIT MEDICAL SYSTEMS, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ '000)
  • 202. SPECTRANETICS INTERNATIONAL B.V - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
  • 203. VARIAN MEDICAL - NET REVENUE BY MARKET AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 204. TELEFLEX MEDICAL - NET REVENUE BY MARKET SEGMENT AND GEOAGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 205. ABBOTT VASCULAR DEVICES - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 206. MEDTRONIC, INC - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2012 (IN US$ MILLION)
  • 207. AORTECH INTERNATIONAL PLC - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
  • 208. VOLCANO CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 & 2012 (IN US$ '000)
  • 209. PHILIPS MEDICAL SYSTEMS - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 & 2012 (IN US$ '000)
  • 210. ATCOR MEDICAL HOLDINGS LIMITED - NET REVENUE BY GEOAGRAPHY, FOR 2012 AND 2013 (IN US$ MILLION)
  • 211. LIDCO GROUP PLC - NET REVENUE BY PRODUCTS AND GEOGRAPHY, FOR 2011-2013 (IN GBP£ '000)
  • 212. SORIN GROUP USA, INC. - NET REVENUE BY MARKET SEGMENT AND GEOAGRAPHY, 2011-2013 (IN EURO MILLION)
  • 213. THORATEC CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 & 2012 (IN US$ '000)
  • 214. STEREOTAXIS, INC. - NET REVENUE BY PRODUCT AND GEOGRAPHY, FOR 2011 & 2012 (IN USD)
  • 215. F.HOFFMANN-LA ROCHE LTD - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN CHF MILLION)
  • 216. PULSION MEDICAL SYSTEMS SE - NET REVENUE BY PRODUCT AND GEOGRAPHY, FOR 2012-2013 (IN EURO '000)
  • 217. NOVADAQ TECHNOLOGIES INC - NET REVENUE BY CATEGORY AND GEOGRAPHY, FOR 2011-2013 (IN USD)
  • 218. SIEMENS MEDICAL SOLUTIONS USA, INC. - NET REVENUE BY GEOGRAPHY AND MARKET SEGMENT, FOR 2012 AND 2013 (IN € MILLION)
  • 219. FUKUDA DENSHI CO. LTD - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN MILLION YEN)
  • 220. NIHON KOHDEN CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN MILLION YEN)
  • 221. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 AND 2012 (IN YUAN)
  • 222. ASAHI KASEI CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN '¥' YEN)

KEY COMPANY PROFILES

  • NORTH AMERICA
  • ALERE, INC.
  • CARDIOROBOTICS, INC.
  • INTERFACE BIOLOGICS, INC.
  • MERIDIAN HEALTH SYSTEM, INC
  • CARDIVA MEDICAL, INC.
  • LOMBARD MEDICAL TECHNOLOGIES PLC
  • DELTEX MEDICAL GROUP PLC
  • BIOTELEMETRY, INC.
  • BIOHEART, INC.
  • ASAHI INTECC CO., LTD.
  • ANGIODYNAMICS, INC.
  • MERIT MEDICAL SYSTEMS, INC.
  • MOLECULAR DEVICES, LLC
  • ACCELLENT, INC.
  • MEDTRONIC, INC.
  • ABBOTT VASCULAR DEVICES
  • CAMBRIDGE HEART, INC.
  • GREATBATCH, INC.
  • ABIOMED, INC.
  • ADVANSOURCE BIOMATERIALS CORPORATION
  • ATRICURE, INC.
  • ATRIUM MEDICAL CORPORATION
  • BIOPHAN TECHNOLOGIES, INC.
  • BIOSENSE WEBSTER, INC.
  • BOSTON SCIENTIFIC CORPORATION
  • CARDIAC SCIENCE CORPORATION
  • CARDIACASSIST, INC.
  • CARDICA, INC.
  • COOK GROUP INCORPORATED
  • CORDIS CORPORATION
  • CRYOLIFE INC.
  • MAQUET GMBH & CO. KG
  • DIGIRAD CORPORATION
  • EDWARDS LIFESCIENCES, LLC.
  • ENDOLOGIX INCORPORATED
  • ISSYS SENSING SYSTEMS, INC
  • APTUS ENDOSYSTEMS, INC.
  • FLUXION
  • JOHNSON & JOHNSON
  • KONINKLIJKEDSM N.V.
  • MEDRAD, INC.
  • BIOCLINICA
  • MILLAR INSTRUMENTS, INC
  • MONEBO TECHNOLOGIES, INC.
  • MORTARA INSTRUMENT, INC.
  • SIEMENS MEDICAL SOLUTIONS USA, INC.
  • SONOSITE, INC.
  • SORIN GROUP USA, INC.
  • ST. JUDE MEDICAL
  • STEREOTAXIS, INC.
  • TELEFLEX, INC.
  • CARDIOVASCULARSYSTEMS, INC.
  • TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
  • TERUMO HEART, INC.
  • THORATEC CORPORATION
  • VICOR TECHNOLOGIES, INC.
  • VOLCANO CORPORATION
  • COMPUMED, INC.
  • PULSION MEDICAL SYSTEMS SE
  • 3M HEALTHCARE
  • BAXTER INTERNATIONAL INC.
  • BECTON, DICKINSON & CO.
  • NOVADAQ TECHNOLOGIES INC.
  • SCOTTCARE CARDIOVASCULAR SOLUTIONS
  • VARIAN MEDICAL SYSTEMS, INC.
  • THERMEDICS, INC.
  • LEVITRONIX, LLC
  • SUNSHINE HEART, INC.
  • ACCUTECH, LLC
  • ASH ACCESS TECHNOLOGY, INC.
  • C. R. BARD, INC.
  • CONMED CORPORATION
  • HOSPIRA, INC.
  • SURGICAL SPECIALISTIES CORPORATION
  • CARDIUM THERAPEUTICS, INC.
  • CIRCULITE, INC.
  • CARDIOCOMM SOLUTIONS, INC.
  • EUROPE
  • BERLIN HEART GMBH
  • ESAOTE S.P.A
  • SOPHION BIOSCIENCE A/S
  • BIOTRONIK GMBH & CO. KG.
  • DRÄGER MEDICAL AG & CO. KG
  • BIOTEQUE CORPORATION
  • SPECTRANETICS INTERNATIONAL B.V
  • AORTECH INTERNATIONAL, PLC.
  • APC CARDIOVASCULAR, LTD.
  • ARTERIAL REMODELING TECHNOLOGIES
  • GE HEALTHCARE
  • LIDCO GROUP PLC
  • PHILIPS MEDICAL SYSTEMS
  • SMITH & NEPHEW PLC
  • VASCULAR CONCEPTS
  • AMBU A/S
  • FLEMING MEDICAL LIMITED
  • COVIDIEN PLC
  • ASIA-PACIFIC
  • NIHON KOHDEN CORPORATION
  • ALL PRO CORPORATION
  • FUKUDA DENSHI CO., LTD.
  • SICHUAN JINJIANG ELECTRONIC SCIENCE AND TECHNOLOGY CO., LTD
  • SYNCARDIA SYSTEMS, INC.
  • MICROPORTS MEDICAL
  • LEPU MEDICAL
  • BEIJING ANZHEN HOSPITAL
  • FUDAN UNIVERSITY ZHONGSHAN HOSPITAL
  • INDRAPRASTHA APOLLO HOSPITAL
  • SAHAJANAND MEDICAL TECHNOLOGIES PVT.,LTD.
  • OPTO CIRCUITS INDIA LIMITED
  • ASAHI KASEI CORPORATION
  • ASIAN HEART INSTITUTE
  • NARAYANA HRUDAYALAYA
  • USCOME LIMITED
  • HEARTWARE LTD.
  • BIOSENSORS INTERNATIONAL GROUP, LTD.
  • ATCOR MEDICAL HOLDINGS LIMITED
  • CATHRX LTD
  • TTK HEALTHCARE
  • GOODMAN CO., LTD.
  • REST OF WORLD
  • INSPIREMD LTD.
  • ITGI MEDICAL LTD.
  • MEDINOL, LTD.
  • GAMIDA CELL LTD.
  • AEROTEL MEDICAL SYSTEMS, LTD.
Back to Top